Translate Bio, Inc. (24)

Browse by Contract Category

Contracts

Separation Agreement, dated December 27, 2020, by and between the Registrant and John R. Schroer (Filed With SEC on March 1, 2021)
Indenture of Lease, dated November 3, 2020, by and between the Registrant and Boston Properties Limited Partnership (Filed With SEC on March 1, 2021)
Third Amendment to Exclusive Patent License Agreement, dated June 12, 2020, between the Massachusetts Institute of Technology and Shire AG, dated as of November 1, 2013, as amended (Filed With SEC on August 6, 2020)
Supply Agreement, dated June 22, 2020, by and between Translate Bio MA Inc. and Sanofi Pasteur Inc (Filed With SEC on August 6, 2020)
Amendment to Letter Agreement, dated March 11, 2020, by and between the Registrant and Ronald C. Renaud, Jr (Filed With SEC on March 12, 2020)
Form of Stock Option Agreement under the 2021 Inducement Stock Incentive Plan (Single Trigger Acceleration) (Filed With SEC on March 1, 2021)
Form of Stock Option Agreement under the 2021 Inducement Stock Incentive Plan (Double Trigger Acceleration) (Filed With SEC on March 1, 2021)
Form of Stock Option Agreement under the 2021 Inducement Stock Incentive Plan (No Acceleration) (Filed With SEC on March 1, 2021)
2021 Inducement Stock Incentive Plan (Filed With SEC on March 1, 2021)
First Amendment, dated September 22, 2020 to Suite Retention and Development Agreement, dated September 9, 2019, by and between Albany Molecular Research, Inc. and the Registrant (Filed With SEC on November 5, 2020)
Securities Purchase Agreement, dated June 22, 2020, by and between the Registrant and Sanofi, a French corporation (Filed With SEC on August 6, 2020)
Registration Rights Agreement, dated July 20, 2020, by and between the Registrant and Sanofi, a French corporation (Filed With SEC on August 6, 2020)
Second Amendment to the Collaboration and License Agreement, dated June 22, 2020, by and between Translate Bio MA, Inc. and Sanofi Pasteur Inc (Filed With SEC on August 6, 2020)
Underwriting Agreement, dated June 25, 2020, by and among the Company, Goldman Sachs and Co. LLC, SVB Leerink LLC, Evercore Group L.L.C. and the selling stockholder of the Company... (Filed With SEC on June 26, 2020)
First Amendment to the Collaboration and License Agreement, dated March 26, 2020, by and between Translate Bio MA, Inc. and Sanofi Pasteur, Inc (Filed With SEC on May 7, 2020)
Amended and Restated Employment Agreement, dated March 11, 2020, by and between the Registrant and Richard Wooster (Filed With SEC on March 12, 2020)
Amended and Restated Employment Agreement, dated March 11, 2020, by and between the Registrant and John R. Schroer (Filed With SEC on March 12, 2020)
Amended and Restated Employment Agreement, dated March 11, 2020, by and between the Registrant and Brian Fenton (Filed With SEC on March 12, 2020)
Description of Registrants Securities (Filed With SEC on March 12, 2020)
Suite Retention and Development Agreement, dated September 9, 2019, by and between Albany Molecular Research Inc. and the Registrant (Filed With SEC on November 6, 2019)
Underwriting Agreement, dated September 17, 2019, by and among the Company and Citigroup Global Markets Inc., Jefferies LLC and SVB Leerink LLC (Filed With SEC on September 18, 2019)
Letter Agreement, dated August 6, 2015, as amended on October 18, 2017, by and between the Registrant and Brian Fenton (Filed With SEC on May 9, 2019)
Securities Purchase Agreement, dated April 30, 2019, by and among the Registrant and the other parties thereto (Filed With SEC on May 1, 2019)
Registration Rights Agreement, dated April 30, 2019, by and among the Registrant and the other parties thereto (Filed With SEC on May 1, 2019)